Fidelis Animal Health

Curated by Signal

Developer of therapeutics for animal health

Overview

Developer of therapeutics for animal health. It offers extended-release buprenorphine formulation for post-procedural pain in mice and rats and an extended-release NSAID for rodents and other small animals.

Key facts

Founded: 2016
Headquarters: North Brunswick, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Opal
AI-powered assistant for therapists managing documentation and client interactions
Health TechnologyNew York, United States
CoVocis
Online community platform for users dealing with mental disorders
Health TechnologyMaumee, United States
Mango Sciences
Provides an analytics platform for clinical data for precision medicine and population health
Health TechnologyBoston, United States

About Fidelis Animal Health

What does Fidelis Animal Health do?

Developer of therapeutics for animal health.

Where is Fidelis Animal Health headquartered?

Fidelis Animal Health is headquartered in North Brunswick, United States.

When was Fidelis Animal Health founded?

Fidelis Animal Health was founded in 2016.

Which sector is Fidelis Animal Health in?

Fidelis Animal Health operates in Health Technology.

Who are Fidelis Animal Health's competitors?

Companies similar to Fidelis Animal Health include Opal, CoVocis, and Mango Sciences.